CDC ENTEBBE

πŸ‡ΊπŸ‡¬Uganda
Ownership
-
Employees
-
Market Cap
-
Website

Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change

First Posted Date
2005-07-13
Last Posted Date
2024-05-29
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
1564
Registration Number
NCT00119067
Locations
πŸ‡ΊπŸ‡Έ

University of Alabama, Birmingham (UAB), Birmingham, Alabama, United States

πŸ‡ΊπŸ‡Έ

Mayo Clinic, Rochester, Minnesota, United States

πŸ‡ΊπŸ‡Έ

Walter Reed Army Institute for Research (WRAIR), Silver Spring, Maryland, United States

and more 2 locations

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Phase 4
Completed
Conditions
First Posted Date
2005-07-13
Last Posted Date
2007-03-19
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
4000
Registration Number
NCT00119080

Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-07-13
Last Posted Date
2021-02-10
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
2413
Registration Number
NCT00119106
Locations
πŸ‡ΉπŸ‡­

Thailand Ministry of Public Health - U.S. CDC Collaboration, Nonthaburi, Thailand

Home-based AIDS Care Project

Not Applicable
Terminated
Conditions
First Posted Date
2005-07-13
Last Posted Date
2012-09-11
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
1000
Registration Number
NCT00119093
Locations
πŸ‡ΊπŸ‡¬

Tororo Hospital/CDC-Uganda, Tororo, Uganda

Treatment and Management of Women With Bleeding Disorders

First Posted Date
2005-05-19
Last Posted Date
2007-03-13
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
100
Registration Number
NCT00111215
Locations
πŸ‡ΊπŸ‡Έ

The Mayo Clinic, Rochester, Minnesota, United States

πŸ‡ΊπŸ‡Έ

UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Michigan State University, East Lansing, Michigan, United States

and more 3 locations

Botswana Tenofovir Oral HIV Prophylaxis Trial

Phase 2
Terminated
Conditions
First Posted Date
2005-05-18
Last Posted Date
2007-03-19
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
1200
Registration Number
NCT00111150
Locations
πŸ‡§πŸ‡Ό

BOTUSA HIV Prevention Research Unit, Francistown and Gaborone, Botswana

πŸ‡ΊπŸ‡Έ

Centers for Disease Control and Prevention, Atlanta, Georgia, United States

Intermittent Preventive Treatment With Antimalarials in Kenyan Infants

Not Applicable
Completed
Conditions
First Posted Date
2005-05-18
Last Posted Date
2012-09-27
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
1516
Registration Number
NCT00111163
Locations
πŸ‡°πŸ‡ͺ

Lwak, Abidha, Ongielo and Saradidi clinics, Asembo (Rarieda Division), Nyanza Province, Kenya

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Phase 2
Completed
Conditions
First Posted Date
2001-09-10
Last Posted Date
2012-06-05
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
20
Registration Number
NCT00023413
Locations
πŸ‡ΊπŸ‡Έ

Chicago VA Medical Center (Lakeside), Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

Johns Hopkins University School of Medicine, Baltimore, Maryland, United States

πŸ‡ΊπŸ‡Έ

Duke University Medical Center, Durham, North Carolina, United States

and more 20 locations

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Phase 2
Completed
Conditions
First Posted Date
2001-09-10
Last Posted Date
2005-09-13
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
150
Registration Number
NCT00023426
Locations
πŸ‡ΊπŸ‡Έ

Thomas Street Clinic, Houston, Texas, United States

πŸ‡ΊπŸ‡Έ

New York University School of Medicine, New York, New York, United States

πŸ‡ΊπŸ‡Έ

University of California, San Francisco, San Francisco, California, United States

and more 20 locations

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

Phase 2
Completed
Conditions
First Posted Date
2001-09-10
Last Posted Date
2005-09-13
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
150
Registration Number
NCT00023348
Locations
πŸ‡ΊπŸ‡Έ

Denver Department of Public Health and Hospitals, Denver, Colorado, United States

πŸ‡ΊπŸ‡Έ

Hines VA Medical Center, Hines, Illinois, United States

πŸ‡¨πŸ‡¦

University of Manitoba, Winnipeg, Manitoba, Canada

and more 20 locations
Β© Copyright 2024. All Rights Reserved by MedPath